SSONEWSNewsletter of The Society of Surgical Oncology, Inc. www.surgonc.org Summer 2009

Society of Surgical Oncology • 85 West Algonquin Road • Suite 550 • Arlington Heights IL 60005 • 847/427-1400

ore than 1,200 surgeons partici-pated in a world-class scientificprogram that promoted a greater

understanding of emerging technologiesand novel approaches to solid tumortreatment during the 62nd AnnualCancer Symposium, March 4 – 8, inPhoenix, AZ.

Attendance by non-physicians, spousesand guests, media representatives andexhibitors brought the meeting’s totalregistration to 1,627 – one of thehighest in SSO history.

The Society introduced several newprograms for the 2009 meeting thatwere very well received by those inattendance, Scientific ProgramCommittee Chair Dr.David C.Linehan, St. Louis, MO, reports.

“Attendee feedback was extremelypositive, especially for sessions that madetheir debut in Phoenix,” he explains. “Themeeting’s timely presentations explorednew technology, reviewed importantissues in health care policy and advocacy,and offered a forum for productive discus-sion of emerging therapies and ongoingcontroversies in surgical oncology.”

A well-attended pre-meeting educationalprogram, developed by Dr. Peter Beitsch,Dallas, TX, and the Society’s CommunitySurgical Oncologists Committee, provideda comprehensive update on breast cancer.The full-day workshop, offered practical,

hands-on interaction on topics rangingfrom genetic pathology and breast imagingto practical oncoplastic surgery and com-munity-oriented research.

“Ninety four registrants attended theinaugural pre-meeting program on breastcancer, which far surpassed our expecta-tions,” Dr. Linehan says.

Plans are already underway for a 2010pre-meeting workshop focusing on col-orectal cancer and liver metastases.

Other Annual Cancer Symposium high-lights included:

• American Board Certification inSurgical Oncology: Are We AlmostThere? – Moderated by Drs.Fabrizio Michelassi, New York,NY, and Syed A. Ahmad,Cincinnati, OH, the program pro-vided multiple perspectives onboard certification for surgicaloncology from the AmericanCollege of Surgeons, The SurgicalOncology Advisory Council(SOAC), the Accreditation Councilfor Graduate Medical Education(ACGME), and the AmericanBoard of Surgery (ABS).

• Great Debates in Surgical Oncology –Rigorous debates offered American andEuropean perspectives on breast MRIfor locoregional staging and surgicalmanagement of breast cancer, lym-phadenectomy for melanoma metastasisto sentinel lymph nodes, and postopera-

1,627 attend 62nd Annual Cancer SymposiumM

…continued on page 5

Attendees at SSO’s 62nd Annual Cancer Symposium facedimportant issues such as “The War on Cancer: Shifting fromDisappointment to Hope,” the title of Dr. William Cance’sPresidential Address (summarized on page 5).

Inside this issue...Message from the President . . . . . . . . . .2Dr. Fabrizio Michelassi electedSSO President . . . . . . . . . . . . . . . . . . .3Society presents DisparitiesFellowship to Dr. Derrick Cox . . . . . . .3Drs. Celia Chao, Rebekah Whiteawarded $100,000 CIAs . . . . . . . . . . .4Dr. William Cance: Membersmust embrace new therapies . . . . . . . .5Annual Meeting Highlights . . . . . . . .6–7Disparities, OutcomesCommittees established . . . . . . . . . . . .8Membership increases to 2,296 . . . . .10

SSO begins comprehensive Web site redesignSSO has embarked on a total redesign ofits Web site, www.surgonc.org, followinga comprehensive review by Web SiteCommittee members to develop a list ofdesired functions and capabilities, com-mittee chair Dr. Samuel Singer, NewYork, NY, reports.

The new Web site will offer dedicatedpages for Society committees, a robustCME application, improved search fea-tures, an external site link for member-published articles, a legislative and regula-

tory news section, and a range of otheruser benefits.

“Our goal is to create an Internet resourcethat professionally represents the Society,”Dr. Singer explains. “The new Web sitewill improve our ability to provide usefulinformation and services, promote thecontinued education of our membership,and enhance the site’s functionality.”

An essential component of the redesignproject includes creation of Web pages

…continued on page 4

This issue of SSO News supported by a grant from Myriad Genetic Laboratories, Inc.

At the start of my presidency, I turn to 1989, the year when Ijoined the SSO. Our Society had 300 members, the scientificmeeting had no simultaneous sessions and the treasury could

count on less than $10,000. Well, theSociety has changed dramatically: We nowhave more than 2,200 members, the scien-tific meeting has expanded to four full daysof plenary and parallel sessions, the trea-sury is strong and allows us to foster educa-tion and research projects. In one sentence,the SSO has grown to become the premierorganization for surgical oncology, effec-tively positioned to initiate a number of

new programs and activities that will serve the specialty and ourmembers well into the future. Let me summarize the initiativeswhich will constitute the agenda for the next year.

SSO’s pre-meeting workshop, “A Comprehensive BreastCancer Update for the Practicing Surgeon,” was a resoundingsuccess, thanks to the efforts of the Society’s CommunitySurgical Oncologists Committee and its Chair, Dr. PeterBeitsch. Ninety-four SSO members, non-members and breastfellows attended the all-day educational offering, which includ-ed hands-on workshops on APBI, diagnostic and interventionalultrasound, pathology-related treatment, tissue acquisition anda sentinel node station. The SSO Executive Council has alreadyapproved the Committee’s recommendation to conduct a 2010pre-meeting workshop on “Colorectal Cancer and LiverMetastases: A Comprehensive Update for the CommunitySurgeon.” The workshop will be offered on Wednesday,March 3, in St. Louis, MO, immediately preceding the SSOAnnual Cancer Symposium.

The SSO has been pursuing a certificate of subspecialty inadvanced surgical oncology. The Thursday afternoon sympo-sium in Phoenix, “American Board Certification in SurgicalOncology: Are We Almost There?” offered the perspective ofmany of the organizations involved in this discussion and thenecessary steps required in the lengthy and involved processrequired in such an undertaking. The American Board ofSurgery at its June meeting will discuss the request of theSurgical Oncology Advisory Council to support a certificate ofsubspecialty in advanced surgical oncology.

SSO leaders met with leaders of various international surgicalsocieties as well as many surgical oncologists representingnumerous countries during the 2009 Annual Cancer Symposiumin Phoenix. The discussion focused on ways that the SSOcould effectively collaborate with the international surgicaloncology community, and many excellent ideas were shared.Our goal is to implement a few of the suggestions in conjunctionwith the 2010 Annual Cancer Symposium. You will be hearingmore about the SSO’s efforts to reach out to our international

colleagues over the next many months, including the develop-ment of an “SSO Ambassador Team” and the offering of 2010International Career Development Awards.

As discussed on the front page of this newsletter, the SSO WebSite Committee, staff and a newly-hired vendor are beginningwork on a comprehensive redesign of the SSO Web site. Afully enhanced and redesigned Web site will better enable theSociety to serve the full surgical oncology domestic and interna-tional community and assist with our membership expansionefforts. The SSO Executive Council has committed a significantamount of financial resources to the effort. Curt Mattson hasbeen hired as the Society’s new full-time Web/CommunicationsManager with a first assignment to work with the Web SiteCommittee and vendor to oversee the development and launchof the new Web site targeted for later this year.

Over the past few years, the Accreditation Council forContinuing Medical Education (ACCME) has been working toupdate and strengthen its accreditation criteria. This has led theACCME to requiring more from its accredited bodies, such asthe SSO. Greater efforts are requested relative to identifyingpractice gaps as a way to inform specific education programs;measuring and demonstrating the impact of the CME offeringon the learner and ultimately its impact on patient care; makinga concerted effort to remove any potential conflict of interestfrom educational offerings. The ACCME auditors will be inattendance at the 2010 SSO Annual Cancer Symposium for a“live” assessment of these requirements. In the meanwhile, theSSO is preparing for the ACCME reaccreditation processthat will take place in the final quarter of 2009. If you areasked to serve as a faculty member for the 2010 meeting,please work with the Scientific Program Committee mem-bers and staff to ensure that all of the required ACCMEdocumentation needed for your presentation is completedand submitted in a timely manner. I thank you in advance foryour cooperation.

In light of all of these exciting initiatives and the others con-tained in the current three-year strategic plan, the SSOExecutive Council has directed the Finance Committee to initi-ate a comprehensive review of all SSO revenues and expenses.Working in conjunction with staff, the Finance Committeereported its initial findings and recommendations to theExecutive Council during its June teleconference. Our goal is toensure that the Society’s budget and resources are alignedwith the SSO strategic plan and our overall programmaticpriorities.

I am honored to be your President, and I thank you for yourongoing support of the Society. Please let me know how the SSOand I can better serve you.

2

A domestic and international agenda for 2009-10By Dr. Fabrizio Michelassi

M E S S A G E F R O M T H E P R E S I D E N T

Dr. Fabrizio Michelassi

Dr. Fabrizio Michelassi,New York, NY, wassworn-in as SSOPresident at the Society’sannual business meetingin Phoenix. He succeedsDr.William G. Cance,Buffalo, NY.

Dr. Michelassi is theLewis Atterbury StimsonProfessor of Surgery andChairman of theDepartment of Surgeryat Weill Medical Collegeof Cornell University,and Surgeon-in-Chief at the New York Presbyterian Hospital-Weill Cornell Medical Center.

An SSO member since 1989, Dr. Michelassi has previouslyserved on the Executive Council as President-elect, Secretary,Council Member and Councillor-at-Large. He was chair of theScientific Program Committee for the 2001 Annual Meeting inWashington, D.C., and has served on several committees, includ-ing the Continuing Medical Education, Local Arrangements, andClinical Affairs Committees.

Dr. Michelassi graduated summa cum laude from the Universityof Pisa, School of Medicine, Italy, then completed residencies atthe University of Pisa, Department of Surgery, and New YorkUniversity.

Other members elected to serve on the SSO Executive Council are:

• Dr.Mitchell C. Posner, Chicago, IL (President-elect);

• Dr. James S. Economou, Los Angeles, CA (Vice President);

• Dr. Kelly M. McMasters, Louisville, KY, (Executive CouncilMember);

• Dr. Ronald J. Weigel, Iowa City, IA, (Executive CouncilMember);

• Dr. Sharon M. Weber, Madison, WI, (Councillor-at-Large). �

Dr. Fabrizio Michelassi elected SSO President

Dr. Derrick D. Cox, Washington, D.C.,was named recipient of the American

Cancer Society/SSOCancer DisparitiesFellowship at theAnnual CancerSymposium inPhoenix, DisparitiesCommittee ChairDr. Lisa A.Newman, AnnArbor, MI, reports.

Dr. Cox will spend approximately fourmonths working with epidemiologists andpublic health specialists on the study ofcancer disparities at the American CancerSociety (ACS) home office in Atlanta, GA.The fellowship begins in July.

“The ACS/SSO Cancer DisparitiesFellowship represents a strategic focus byboth groups on reducing cancer incidence

and mortality in underserved populations,”Dr. Newman explains. “It is designed toposition surgical oncology trainees forindependent research careers that willdirectly impact cancer disparities.”

Dr. Cox is complet-ing his generalsurgery residency atGeorgetownUniversity Hospital,and will begin train-ing as a SurgicalOncology Fellow atRoswell Park CancerInstitute, Buffalo, NY, this summer. Hegraduated from The University of Texasat Houston Medical School, and has com-pleted fellowships in immunotherapy andsurgical oncology from the NationalCancer Institute at the National Institutesof Health, Bethesda, MD.

“The health services and epidemiologygroups at the American Cancer Society,coupled with their outreach programs,offer a unique opportunity to gain exper-tise in the use of national data sets and

their directapplication ofthese findings inaffectingchange,” Dr.Cox wrote onhis application.“The ACS/SSODisparitiesFellowship will

provide an excellent base for advancingmy skills in epidemiology and health poli-cy in order to strategically focus on reduc-ing cancer incidence and mortality in pop-ulations that are affected disproportion-ately by the burden of cancer.” �

Dr. Derrick Cox named recipient of firstACS/SSO Disparities Fellowship

3

SSO Executive CommitteePresident: Dr. Fabrizio Michelassi, New York, NY

President-elect: Dr.Mitchell Posner, Chicago, IL

Vice President; Dr. James Economou, Los Angeles, CA

Secretary: Dr.Monica Morrow, New York, NY

Treasurer: Dr. V. Suzanne Klimberg, Little Rock, AR

Dr. Fabrizio Michelassi (right), 2009-10SSO President, is congratulated by his pre-decessor Dr. William G. Cance.

Dr. Derrick Cox

“The ACS/SSO DisparitiesFellowship represents astrategic focus by bothgroups on reducing cancerincidence and mortality inunderserved populations.”

4

dedicated specifically to SSO committees.These pages will enable committee mem-bers to upload and share documents, postupcoming event schedules, and communi-cate with committee members via e-mail.

Other planned enhancements for the newWeb site include:

• Clinical trial “tracker,” where autho-rized users may post the latest clinicaltrial information as it develops.

• Custom-built CME application,allowing SSO members to performonline tests and reviews. Upon comple-tion of a course, users will be able toprint a certificate.

• Integration of the SSO and Annals of

Surgical Oncology Web sites, allowingone-click access and automatic authenti-cation.

• SSO member section that allowsmembers to update online profiles, paydues, and subscribe to the SSO Listserv.

• Survey section that will allow theSociety to develop and distributeExecutive Council-approved surveys.

• Legislative/regulatory news sectionthat automatically draws news fromexisting feeds.

• Surgical oncologist locator to improvethe public’s ability to find local medicalprofessionals. The locator will allow vis-itors to search by distance, zip code or

country. Results will display surgicaloncologists’ office address, phone num-ber and Web site.

•Member-published articles, throughlinks to external sites.

• Events calendar featuring upcomingdisease-specific meetings.

Following the Web Site Committee’sreview of 32 redesign proposals, SSOawarded the contract to Lincolnwood, IL-based LiquidPrint to begin building thenew Web site. The Executive Council alsoapproved the hiring of a full-timeWeb/Communications Manager to sup-port the development and continued evo-lution of the new site. �

Society begins Web site redesign …continued from page 1

SSO presented two new $100,000 ClinicalInvestigator Awards (CIAs) during the62nd Annual Cancer Symposium inPhoenix, Fellowship and Research GrantCommittee Chair Dr. Kenneth K.Tanabe, Boston, MA, announced.

The awards promote patient-orientedresearch through the training of surgicaloncologists in clinical and translationalscience. 2009 award winners are:

• Dr. Celia Chao, Galveston, TX,“Stromal Biomarkers and ColorectalCancer Recurrence.” (Funded by a grantfrom Genentech)

• Dr. Rebekah R. White, Durham, NC,“Validation of Gene Expression Profilesthat Predict Pancreatic CancerResponse to Gemcitabine.” (Funded bya grant from Amgen)

Awards will be funded for two years($50,000 per year) and began in April2009. Award recipients will submit aprogress report in March 2010, a finalreport in March 2011, and make briefpresentations at the 2011 Annual CancerSymposium in San Antonio, TX.

To date, SSO has awarded funding to 10investigators through the ClinicalInvestigator Award program. Drs. Peter

J. Allen, Ronald P. DeMatteo and TariKing, New York, NY; Anthony A. Lucci,Jr., Houston, TX, and Sam S. Yoon,Boston, MA, were the recipients of CIAfunding in 2008. 2007 recipients wereDrs. John A. Olsen, Jr., Durham, NC;Malcolm V. Brock, Baltimore, MD; andHerbert Chen, Madison, WI.

SSO will present two additional CIAslater this year, including one specifically

for breast cancer research (see articlebelow). Information on the 2010 CIAs,including availability, deadlines andapplication information, is available onthe SSO Web site, www.surgonc.org.The deadline to submit applications isJuly 1.

Applicants must be SSO members andsurgical oncologists who have completedtheir training in the last 10 years. �

SSO presents two Clinical Investigator Awards

Society to award second CIA in breast cancer researchSSO will offer its second $100,000Clinical Investigator Award (CIA) tofund patient-oriented breast cancerresearch beginning in October 2009.

Applications for the CIA in BreastCancer Research, funded by Susan G.Komen for the Cure®, are due July 1.Applicants must be surgical oncologistswho completed their training within thepast 10 years and be SSO members.

Funding will be given to the award win-ner’s sponsoring institution, and may beused to support the applicant’s salary,research fellows or staff support, tuition,travel and supplies.

Applications for the ClinicalInvestigator Award in Breast CancerResearch are available at the Society’sWeb site, www.surgonc.org.Completed applications should be sub-mitted electronically no later than 11:59p.m., July 1. The winner will be notifiedin September. Award funding will com-mence October 1.

Dr. Tari King, New York, NY, wasnamed recipient of the first CIA inBreast Cancer Research last year for herstudy, “A Genetic Analysis of theInvasive Breast Cancer Risk Associatedwith Lobular Carcinoma in Situ.” �

5

tive chemoradiation vs. perioperative chemotherapy for adeno-carcinoma of the stomach.

• Poster Discussion Sessions – More than 300 posters on dis-play during this interactive session encouraged meaningful dis-cussion and constructive critique of recent research findings.

•Meet the Professor Breakfast sessions – Eighteen sessionsfeaturing speakers of international prominence discussed the lat-est challenges in surgical oncology in a more intimate setting.

During the President’s Banquet, Dr.William G. Cance, Buffalo,NY, presented cancer research advocates and philanthropistsAnne and Donna Gioia, of Buffalo, NY, with the James Ewing

Layman Award for their success in raising more than $160 mil-lion to fund innovative cancer research.

In addition, 2006-07 SSO President Dr. Raphael E. Pollock,Houston, TX, honored 2001-02 President Dr. John E.Niederhuber, Bethesda, MD, Director of the National CancerInsititure (NCI), during the meeting’s Annual HeritagePresentation.

Webcasts of most presentations from the Annual CancerSymposium are available for viewing on the SSO Web site,www.surgonc.org, where members may also purchase theAnnual Meeting on CD-ROM. �

1,627 attend Annual Cancer Symposium …continued from page 1

Surgery will remaina mainstay of cancertreatment for theforeseeable future,but SSO must beready to embracethe potential of newtherapies that aretransforming patientcare and offering

new hope in the battle against the disease,Dr.William G. Cance, Buffalo, NY, toldmembers during his Presidential Addressat the Annual Cancer Symposium.

“We are moving toward a transformation inhow we treat patients, and that is where thisnew hope comes from,” he declared. “Toget there, we have to move from traditionthrough transition to transformation.”

Predicting that cancer therapies will becomeless toxic and, increasingly, be administeredorally, Dr. Cance offered a present-dayexample of how “transformational” care isaiding “traditional” surgical care.

“Think what Gleevec® has done. We canprescribe this drug to our patients withadvanced gastrointestinal stromal tumors,watch them shrink, then operate and getclear margins,” he explained. “This trans-formation is already happening. Thinkwhat will happen as we get new and betterGleevecs. Think what this will mean forpatients, for health care economics, andfor surgical oncologists.”

Recalling a college friend, John, who diedfrom cancer more than 30 years ago, Dr.Cance focused audience attention on acritical question.

“So, why can’t we stop cancer? Theproblem for you today is the sameproblem we had for John – the individ-ual biology of the tumor determinespatient outcome, and we have had verylittle influence on that biology over theyears,” he explained. “While we havemade significant progress in the surgi-cal extirpation of cancer – and I don’twant to minimize our successes as sur-geons – we still have a long way to go.”

With new knowledge and insights gleanedover the past several years, surgical oncol-ogists are headed down the path tobecome complete caregivers for the can-cer patient, Dr. Cance explained. Theability to molecularly dissect a tumor andtailor treatment with less toxic, moreeffective drugs is a transformational timein the history of cancer therapy.

“Remember, we are the gatekeepers for thesolid tumor patients, and we must remaininvolved in all aspects of their care. But inorder to do this, we must think beyond theoperation. It’s the only way for us to main-tain our status as oncologists and notbecome technicians,” he explained.

The Society is uniquely positioned torespond to this challenge, he added, but

“it will require ongoing investment in ourmembers, their education and their clini-cal practices.”

He proposed an expansion of SSO’s supportfor clinical research, including disparitiesresearch, community training for clinicaltrials, as well as more traditional approachesin breast, pancreatic and other cancers.

To realize this proposal, Dr. Cance chal-lenged Society leaders to develop a moremethodical plan for prioritizing resourceallocation, and encouraged all members toget involved.

“We must invest now,” he urged. “Withthe transformation we are seeing in cancercare, we simply cannot afford to wait.”

In closing, Dr. Cance cited CharlesDarwin, who observed, “It is not thestrongest species that survives, nor themost intelligent, but the one most respon-sive to change.”

“If we are to maintain a leadership role inthe treatment of cancer patients, we mustrespond to change,” he said. “We mustembrace changes, teach them to all ourmembers, and partner with surgical oncol-ogists in all practices, across the world.That’s what we do best.

“We’ve done it before with minimally-invasive surgery and sentinel lymphnodes. I am confident we will adapt to thetransformational changes in our field.” �

S S O P R E S I D E N T I A L A D D R E S S

Dr. William Cance

Dr. Cance: Society members must embracenew therapies to maintain leadership role

6

A group of 19 international leaders in surgical oncology convened in Phoenix to discucollaborative activities with the SSO.

Dr. Steven Trocha (left) and undergraduate students participatingin his summer clinical oncology program review the latest research

during the meeting’s Poster Discussion Session.

New cancer treatmeproducts and servicesdisplay attracted vasnumbers of AnnualCancer Symposiumtrants to the exhibit

Newly elected SSO President Dr. Michelassi (center) celebrateswith SSO Secretary Dr. Morrow and President-Elect Dr.Posner (far left), Past President Dr. Petrelli and Prof.Cornelius van de Velde, President of ESSO (far right).

7

ss possible

American CancerSociety/SSO Basic ScienceLecturer Dr. Edison T. Liu

offered an outlook on,“Genomic Medicine –

Systems Medicine – TheFuture of Medicine.”

ents onst

regis-t hall.

Dr. William Cance poses with James Ewing Lecturer Dr. ShellyEarp (right), winner of the SSO Award of Appreciation for hiscontributions to the Annual Cancer Symposium.

Dr. Richard Karl deliveredan intriguing John WayneClinical Research Lecture,“Forty Years in OperatingRooms and Cockpits.”

Outgoing President Dr. William G. Cancepresents Anne and Donna Gioia (right) withthe James Ewing Layman Award.

SSO Secretary Dr. Monica Morrow (center)joins Drs. Barbara Bass and Vivian Strongduring Thursday night’s Welcome Reception.

Following months of planning and preparation, ScientificProgram Committee Chair Dr. David C. Linehan greetsguests at the Welcome Reception.

8

Society thanks its corporate supporters

Membership approval of amendments to the SSO bylaws has estab-lished the Outcomes Research and Disparities Task Forces as perma-nent standing committees, Constitution and Bylaws CommitteeChair Dr.Thomas W. Mesko, Miami Beach, FL, reports.

The duties of the newly established Disparities Committee are toaddress matters pertaining to health disparities in surgical oncol-ogy as they relate to activities of the Society, the revised bylawsread. The committee’s chair will serve as an ex-officio member ofthe Scientific Program Committee.

Members of the Outcomes Research Committee will advise theExecutive Council on positioning SSO to respond to the impact

of outcomes-related research.

Other amendments approved by the voting membership:

• Enable the chairs of the Clinical Affairs, Community SurgicalOncologists, Constitution and Bylaws, Coding andReimbursement, Disparities, International, Issues andGovernment Affairs, Membership, Outcomes Research, andWeb Site Committees to remain as ex-officio committee mem-bers for one year following the completion of their terms.

• Eliminate the need for membership applicants to be proposedand seconded by Active or Senior Society members. �

Disparities, Outcomes Task Forces established as standing committees

SSO expresses its appreciation to the fol-lowing companies and organizations fortheir generous support of the 62ndAnnual Cancer Symposium, as well as sev-eral other essential Society programsthroughout the year.

• American Cancer Society – Supporterof the American Cancer Society BasicScience Lecture.

• American College of SurgeonsCommission on Cancer – Supporterof the Annual Heritage Presentation.

• Amgen – Supporter of a two-yearClinical Investigator Award and the2009 Abstracts on CD-ROM.

• AngioDynamics – Partial supporter ofPlenary Sessions I-IV on Friday andSaturday.

• AstraZeneca LP – Supporter of a one-year Clinical Investigator Award.

• Bristol-Myers Squibb – Co-supporterof the Thursday symposia, “Biomarkers& Personalized Treatment in CancerCare” and “Evidence-Based Follow-upin the Cancer Patient” (partial support).

• Covidien – Co-supporter of theSaturday symposium, “Controversies inthe Management of EsophagealCancer.”

• Eli Lilly & Company – Partial sup-porter of the Friday symposium,“Screening and Prophylactic Surgery inHigh Risk Pancreas Cancer Families.”

• Ethicon Endo-Surgery, Inc., aJohnson & Johnson Company –Supporter of the Wednesday pre-meet-ing workshop, “A Comprehensive

Breast Cancer Update for thePracticing Surgeon,” partial supporterof the Thursday symposium, “GreatDebates in Surgical Oncology,” andco-supporter of the Saturday sympo-sium, “Controversies in theManagement of Esophageal Cancer.”

• Genentech – Supporter of a two-yearClinical Investigator Award and theWednesday pre-meeting workshop, “AComprehensive Breast Cancer Updatefor the Practicing Surgeon.”

• Genomic Health, Inc. – Supporter ofthe Wednesday pre-meeting workshop,“A Comprehensive Breast CancerUpdate for the Practicing Surgeon.”

• Hologic – Supporter of the Wednesdaypre-meeting workshop, “A Compre-hensive Breast Cancer Update for thePracticing Surgeon,” and partial sup-porter of the Thursday symposium,“Accelerated Partial Breast Irradiation:The Role of Interdisciplinary Care.”

• ImClone Systems Incorporated –Co-supporter of the Thursday sym-posia, “Biomarkers & PersonalizedTreatment in Cancer Care” and“Evidence-Based Follow-Up in theCancer Patient” (partial support).

• IntraOp Medical Corporation –Partial supporter of the Thursday sym-posium, “Novel Applications ofRadiotherapy in Oncologic Care:Updates for the Surgical Oncologist.”

• James Ewing Foundation – Supporterof the James Ewing Lecture, the JamesEwing Layman’s Award and the HarveyBaker Traveling Fellow Award.

• John Wayne Foundation – Supporterof the John Wayne Clinical ResearchLecture.

•MDS Nordion – Partial supporter ofthe Thursday symposium, “NovelApplications of Radiotherapy inOncologic Care: Updates for theSurgical Oncologist.”

•Myriad Genetic Laboratories, Inc. –Supporter of the Wednesday dinnersymposium, “Demystifying GeneticTesting,” and supporter of the 2009issues of SSO News.

• Onyx Pharmaceuticals/BayerHealthcare Pharmaceuticals –Supporter of the Thursday symposium,“Emerging Therapeutic Approaches toHepatocellular Carcinoma.”

• Schering-Plough – Supporter of theSunday breakfast symposium, “Minimizingand Managing the Toxicity of MelanomaTherapy,” a CME monograph on thesymposium proceedings, and the 2009-10SSO Membership Directory.

• Susan G. Komen for the Cure® –Supporter of the Thursday symposium,“The Primary Tumor in MetastaticBreast Cancer: Biological Questions andClinical Implications,” and a two-yearClinical Investigator Award in BreastCancer Research.

• Varian Medical Systems – Partial sup-porter of the Thursday symposium,“Novel Applications of Radiotherapy inOncologic Care: Updates for theSurgical Oncologist” and the Sundaysymposium, “Local Therapy for SoftTissue Sarcoma.” �

9

Residents applying for the 2009 SSOSurgical Oncology Fellowship or BreastFellowship Matching Programs may down-load applications for both programs fromthe SSO Web site, www.surgonc.org.

Candidates for Surgical OncologyFellowships must submit applications tothe Society’s Executive Office no later thanSeptember 22. Applications for BreastFellowships are due by November 17.

Last year, the two programs placed a com-bined 91 residents in SSO-approved train-ing programs across the U.S. and Canada.Applicants for the 2009 SurgicalOncology Match will be notified of theresults on October 19. SSO will announcethe results of the Breast Fellowship Matchon December 4.

The following institutions will participatein this year’s program:

SURGICAL ONCOLOGY FELLOWSHIP

• Boston University/Roger WilliamsMedical Center, Boston, MA;

• City of Hope National MedicalCenter, Duarte, CA;

• Fox Chase Cancer Center,Philadelphia, PA;

• Dana Farber-Partners SurgicalOncology Fellowship, Boston, MA;

• H. Lee Moffitt Cancer & ResearchInstitute, Tampa, FL;

• John Wayne Cancer Institute, SantaMonica, CA;

• The Johns Hopkins Hospital &Sidney Kimmel Cancer Center,Baltimore, MD;

• McGill University, Montreal, Quebec,Canada;

• M.D. Anderson Cancer Center,Houston, TX

• Memorial Sloan-Kettering CancerCenter, New York, NY;

• Ohio State University, Columbus, OH;

• Roswell Park Cancer Institute,Buffalo, NY;

• University of Calgary, Calgary, AB,Canada;

• University of Chicago, Chicago, IL;

• University of Louisville JamesGraham Brown Cancer Center,Louisville, KY;

• University of Miami School ofMedicine, Miami, FL;

• University of Pittsburgh, Pittsburgh,PA;

• University of Toronto, Toronto, ON,Canada;

• Virginia Commonwealth University,Richmond, VA.

BREAST FELLOWSHIP

• Akron General Medical Center,Akron, OH;

• Allegheny General Hospital,Pittsburgh, PA;

• Anne Arundel Medical Center,Annapolis, MD;

• Baylor University Medical Center,Dallas, TX;

• The Beth Israel Medical Center/St.Luke’s Roosevelt Hospital Center,New York, NY;

• Women & Infants Hospital,Providence, RI;

• The Bryn Mawr Hospital, BrynMawr, PA;

• Robert Wood Johnson MedicalSchool, New Brunswick, NJ;

• The Cleveland Clinic Foundation,Cleveland, OH;

• Columbia Presbyterian MedicalCenter, New York, NY;

• Emory University School ofMedicine, Atlanta, GA;

• Fox Chase Cancer Center,Philadelphia, PA;

• Grant Medical Center, Columbus,OH;

• H. Lee Moffitt Cancer Center andResearch Institute, Tampa, FL;

• John Wayne Cancer Institute, SantaMonica, CA;

• Massachusetts General Hospital,Dana Farber Cancer Institute andBrigham & Women’s Hospital,Boston, MA;

• Mayo Clinic, Rochester, MN;

• M.D. Anderson Cancer Center,Houston, TX;

• Memorial Sloan-Kettering CancerCenter, New York, NY;

• Northwestern University, FeinbergSchool of Medicine, Chicago, IL;

• Stanford University School ofMedicine, Stanford, CA;

• University of Arkansas for MedicalSciences, Little Rock, AR;

• University of California at SanFrancisco Breast Care Center, SanFrancisco, CA;

• University of MassachusettsInterdisciplinary Breast FellowshipProgram, Worcester, MA;

• University of Michigan, Ann Arbor,MI;

• University of Pennsylvania BreastCancer Fellowship, Philadelphia, PA;

• University of Pittsburgh MedicalCenter, Magee Women’s Hospital andUniversity of Pittsburgh CancerInstitute, Pittsburgh, PA;

• University of Southern California,Keck School of Medicine, LosAngeles;

• University of Texas SouthwesternCenter for Breast Care, Dallas, TX;

• Washington Cancer Institute at theWashington Hospital Center & theCenter for Breast Health,Washington, D.C.;

• Washington University School ofMedicine, St. Louis, MO;

• William Beaumont Hospital BreastCare Center, Royal Oak, MI. �

Surgical Oncology, Breast FellowshipMatch applications available online

10

Membership increases to record 2,296The addition of 162 new members has increased the Society’s overall membership to a record 2,296, SSO Secretary Dr.MonicaMorrow, New York, NY, reports. New and elevated members include:

ACTIVE MEMBERS

• Syed A. Ahmad, MD• Eduardo Hiroshi Akaishi, MD• Waddah B. Al-Refaie, MD• Daniel Albo, MD, PhD• Kathleen Gardiner Allen, MD• Brian Badgwell, MD• Karen Sarah Barbosa, DO•Charles E. Binkley, MD• Wilbur B. Bowne, MD• Tommy A. Brown, MD• William S. Buice, MD• Joseph A. Califano, III, MD• Ernest Ramsay Camp, MD• Kim James Charney, MD• William G. Cloud, MD• Johannes H. W. De Wilt, MD, PhD• Maria B. Majella Doyle, MD• Hatem M. El Halabi, MD• Hisham El-Bayar, MD• Christian M. Ellis, DO• Marcelo E. Facciuto, MD• Jason M. Foster, MD• Anthony J. Froix, MD• Tom N. Galouzis, MD• Julio Garcia-Aguilar, MD• Carlos A. Garcia-Etienne, MD• Gladys Linda Giron, MD• Elizabeth G Grubbs, MD• Mehran Habibi, MD, MBA• Hank C. Hill, MD• Robert Barry Hird, MD• Nicole C. Hodgson, MD, MSc• Patrick Graves Jackson, MD• Emilio Jimenez, MD• Udai S. Kammula, MD• Matthew H. G. Katz, MD• Jarrod P. Kaufman, MD• Gregory D. Kennedy, MD, PhD• Patricia Rae Kennedy, MD• Susan Beth Kesmodel, MD• John Vincent Kiluk, MD• Ian Komenaka, MD• Laura A. Lambert, MD• Byrne Lee, MD• Quan P. Ly, MD• Najjia N. Mahmoud, MD• Holly S. Mason, MD• John A. Matyas, MD• Edward C McCarron, MD• Sarah McLaughlin, MD

• Elizabeth A. Mittendorf, MD• Robert Clark Moesinger, MD• Pablo Montero-Miranda, MD• Basem B. Morcos, MD• Eric Kaoru Nakakura, MD, PhD• Seigo Nakamuara, MD• Keith E. Nichols, MD• James O. Park, MD• Nilima A. Patwardhan, MD• Stephen Paul Ray, MD• Kathleen Joyce Reilly, MD• Paul Bryan Roach, MD• Jennifer Erica Rosen, MD• Jan G. Rothschild, MD• Walid Salamoun, MD• Umut Sarpel, MD• Randall P. Scheri, MD• Allan E. Siperstein, MD• Hubert E. Spears, Jr., MD• Francesco Stipa, MD• James Sullivan, MD• Kazuaki Takabe, MD, PhD• Konstantin Umanskiy, MD• Gary Unzeitig, MD• Davood Vafai, MD• Masahiko Watanabe, MD• Heather R. Wright, MD• John H. Yim, MD• Raza M. Zaidi, MD• Brian K. Zebrowski, MD

ASSOCIATE MEMBERS

• Rosemary Giuliano, ARNP, MSN• Alaine Kamm, RN, MSN, ACNP

CANDIDATE MEMBERS

• Gerard J. Abood, MD, MS• Vanita Ahuja, MD• Mohammed Khalfan Al-Sibani, MD• Scott P. Albert, MD• Marco Antonio Alcala, MD• Raed Hameed Ali Almarzooq, MD• Amal Ahmed Noor Alrayes, MD• Nirupama Anne, MD• Amit Arora, MD• Ilan D. Avin, MD, Thornhill, ON• Michelle C. Azu, MD• Sanjay Prakash Bagaria, MD• Jennifer Lynn Baynosa, MD• Giovanni Begossi, MD• Emily Catherine Bellavance, MD• Lisa Danielette Benton, MD, MPH

• Richard N. Berri, MD• Karl Y Bilimoria, MD, MS• Cherif N. Boutros, MD,MSc• Matthew Richard Bower, MD• Tawnya Lynn Bowles, MD• Kanesha L. Bryant, MD• Eduardo Careaga, MD• Ravi J. Chokshi, MD• Clancy J. Clark, MD• Aimee M. Crago, MD, PhD• Jeremy Lee Davis, MD• Nicole De Rosa, MD• Zuleika Diaz, MD• George W. Dittrick, MD• Laura S. Dominici, MD• Michael Scott Elmore, MD• Ryan Courtney Fields, MD• Ani J. Fleisig, MD• Fergal Fleming, MD• Richard Samuel Flint, MD, PhD• Valerie Francescutti, MD• Csaba Gajdos, MD• Amir A. Ghaferi, MD• Alyssa M Gillego, MD• Mark I. Gimbel, MD• Evan S. Glazer, MD• Jennifer Lynn Gnerlich, MD• Negar Golesorkhi, MD• Alicia I. Growney, MD• Joseph D. Heyne, MD• Erich S. Huang, MD, PhD• Matthew Timothy Hueman, MD• Jenevieve H. Hughes, MD• Fumito Ito, MD, PhD• Hiromichi Ito, MD• Giorgos C. Karakousis, MD• Wendy Kelder, MD, PhD• Brigid K. Killelea, MD, MPH• T. Peter Kingham, MD• Christine Susan Landry, MD• Peter A. Learn, MD• Shannon C. Lehr, MD• Sydney R. Lillard, MD• Ajay Maker, MD• Jason Marengo, MD• Jerimiah E Mason, MD• Alexander Mathieson, MD• Kandace P. McGuire, MD• Shaun Patrick McKenzie, MD• Tamra McKenzie-Johnson, MD

…continued on page 11

Dr. Ajay Maker, Boston, MA was honoredat the 62nd Annual Cancer Symposium asauthor of the Annals of Surgical Oncologyarticle most cited in 2008.

Annals’ Editor-in-Chief Dr. Charles M.Balch, Baltimore, MD, recognized Dr.Maker and his co-authors – includingSSO members Drs. Udai Kammula andSteven Rosenberg, Bethesda, MD, – onthe accomplishment during the Society’sAnnual Business Meeting in Phoenix.

The article, “Tumor Regression andAutoimmunity in Patients Treated withCytotoxic T Lymphocyte-AssociatedAntigen 4 Blockade and Interleukin 2: APhase I/II Study,” was cited 43 times in

other medical journals last year, according toISI Thompson Scientific Journal CitationReport. The article was published in theDecember 2005 edition of Annals.

“We are privileged to recognize Dr. Makerand his co-authors for their significant con-tribution to Annals, the SSO, and the greaterhealthcare community,” Executive EditorDr.Mark S. Roh, Pittsburgh, PA, says.

“Their paper is indicative of the highquality of editorial submissions featured inSSO’s official journal. This contributionwill encourage further submissions fromauthors who seek publication in journalswith high impact factors and are frequent-ly cited by others,” he adds. �

Dr. Ajay Maker honored by Annalsfor most cited paper in 2008

2009-10 SSO Committee ChairsThe Executive Council has approved the following committee chair appointments forthe 2009-10 program year:COMMITTEES

Clinical Affairs . . . . . . . . . . . . . . . . . . . . .Dr. Stephen E. Ettinghausen, Rochester, NYCommunity Surgical Oncologists . . . . . . . . . . . . . . . .Dr. Peter D. Beitsch, Dallas, TXConstitution and Bylaws . . . . . . . . . . . . . . . .Dr. Thomas W. Mesko, Miami Beach, FLContinuing Medical Education . . . . . . . . . .Dr. David N. Danforth, Jr., Bethesda, MDCoding and Reimbursement . . . . . . . . . . . . . . . . .Dr. Francis R. Spitz, Philadelphia, PACorporate Relations . . . . . . . . . . . . . . . . . . . . . . . . . .Dr. Robert Martin, Louisville, KYDisparities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dr. Lisa A. Newman, Ann Arbor, MIEducation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dr.Mitchell C. Posner, Chicago, ILFellowship and Research Grant . . . . . . . . . . . . . .Dr. Kenneth K. Tanabe, Boston, MAFinance . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dr. V. Suzanne Klimberg, Little Rock, ARInternational . . . . . . . . . . . . . . . . . . . . . . . . . . .Dr. Joseph M. Klausner, Tel Aviv, IsraelIssues and Government Affairs . . . . . . . . . . . . . .Dr.Mark A. Arredondo, Amarillo, TXLocal Arrangements . . . . . . . . . . . . . . . . . . . . . . .Dr. David C. Linehan, St. Louis, MOMembership . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dr.Monica Morrow, New York, NYNominating . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dr. Raphael E. Pollock, Houston, TXOutcomes/Research . . . . . . . . . . . . . . . . . . .Dr. Stanley P.L. Leong, San Francisco, CAPlanning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dr.Mitchell C. Posner, Chicago, ILScientific Program . . . . . . . . . . . . . . . . . . . . . . . .Dr. James C. Cusack, Jr., Boston, MATraining . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dr. Russell S. Berman, New York, NYTraining Program Directors Subcommittee

(Breast) . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dr. Armando Giuliano, Santa Monica, CATraining Program Directors Subcommittee

(Surgical Oncology) . . . . . . . . . . . . . . . . . . . . . .Dr. David L. Bartlett, Pittsburgh, PAWeb Site . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Dr. Samuel Singer, New York, NYTASK FORCES

ABS Advisory . . . . . . . . . . . . . . . . . . . . . . . . .Dr. James E. Goodnight, Sacramento, CAAccreditation/ Certification . . . . . . . . . . . . .Dr. Fabrizio Michelassi, New York, NY �

Membership increasesto record 2,296…continued from page 10

11

• Robert A. Meguid, MD, MPH• James J. Mezhir, MD• Mohammed O. Nassif, MD• Sandeep P. Nayak, MBBS, DNB,

MRCSEd• Viviana M. Negron-Gonzalez, MD• Hidefumi Nishimori, MD• James Ryan Nitzkorski, MD• Laura E. Norton, MD• Steven J. Nurkin, MD• Roshani R. Patel, MD• Kelli K. Pettit, MD• Giao Q. Phan, MD• Brian M. Pinchuk, MD• Rashmi Prakash Pradhan, MD• Matthew S. Pugliese, MD• Poornima B. Rao, MD• Partha S. Ray, MD• Louis Rivera, MD• Christopher Rupp, MD• Carlos A. Santiago Sanchez, MD• Michelino Scarlata, MD• Jean-Claude Schwartz, MD, PhD• Suhail Sharif, MD• Rohit Sharma, MD• Christiana Marie Shaw, MD• Mohd Raashid Ali Sheikh, MD, MS• Jason K. Sicklick, MD• Eric Jay Silberfein, MD• Christopher J Smolock, MD• Naveenraj L. Solomon, MD• April L. Spencer, MD• Prashanth Sreeramoju, MD• Charles R. St. Hill, MD• Bobby Anthony Stevens, DO• Jayme Bruce Stokes, MD• Nancy J. Taft, MD• Robert Tasevski, MBBS, FRACS• Yew Ching Teh, MD• Paige Teller, MD• Shannon Noelle Tierney, MD, MS• Keila E. Torres, MD• Kiran Kalyan Turaga, MD, MPH• Tsafrir Vanounou, MD, MBA• Urs W. Von Holzen, MD• Rachel Beth Wellner, MD• Amanda J. Wheeler, MD• Lisa S. Wiechmann, MD• Tihesha L Wilson, MD

12

SSO will co-sponsor the 2009 AmericanSociety of Clinical Oncology (ASCO)Breast Cancer Symposium, October 8 – 10,in San Francisco.

The discussion-based meeting is devoted tomultidisciplinary breast cancer researchand treatment.

Speakers from top cancer institutions – including SSO membersDrs. Funda Meric-Bernstram, Houston, TX Stephen Edge,Buffalo, NY, and Lisa A. Newman, Ann Arbor, MI – will pre-sent scientific programs that highlight clinically relevant andtranslational science with supporting educational sessions toimpact breast cancer therapy and patient care.

For more information on the ASCO Breast Cancer Symposium,visit www.breastcasymposium.org. �

SSO to co-sponsor ASCO Breast Cancer Symposium

In MemoriamSSO pays tribute to the following Society members who died over the past year.

Dr. J. Harold Cheek, Lindale, TXDr. Richard J. Davies, Hackensack, NJDr. Philip Exelby, New York, NYDr. Robert F. Jones, Issaquah, WA

Dr. Edward F. Lewison, Baltimore, MDDr. Douglas R. Morton, Elgin, ILDr. Martin I. Resnick, Cleveland, OHDr. Edward F. Scanlon, Southlake, TX

Dr. Michael Walker, Columbus, OHDr. Willet F. Whitmore, III, Sarasota, FL

Abstracts for the 63rd Annual CancerSymposium, March 3 – 7, 2010, in St.Louis, MO, may be submitted onlinethrough October 15.

To submit abstracts for review, log ontothe SSO Web site, www.surgonc.org,click on the “Submit Abstracts Online”

icon, then follow the screen prompts.

Authors whose abstracts are accepted fororal or poster presentation will displayand present their research Friday, March5, and Saturday, March 6. Acceptedabstracts will also be published and citedin Annals of Surgical Oncology.

Papers scheduled for publication prior to theCancer Symposium dates, or which havebeen presented at national meetings of otherorganizations, should not be submitted.

Additional information is available on theSSO Web site. �

2010 Annual Meetings abstracts due October 15

2009 Resident Essay, poster contest winners honored in PhoenixFour residents were honored for theirpresentations at the 62nd Annual CancerSymposium in Phoenix, AZ. EachResident Essay Award recipient received a$600 award and reimbursement of travelexpenses to attend the meeting.

SSO also presented two awards recogniz-ing for best basic science and clinicalposters. Meeting attendees selected thewinners from more than 300 posters ondisplay during the meeting’s interactivePoster Discussion Session.

2009 Resident Essay Award winners are:• Dr. J. Patel, Bloomington, IN, Best

Basic Science Research Paper, “Metastatic-Site Specific Differential ProteinExpression and Growth Control inBreast Cancer Through MicroRNAs.”

• Dr. K.J. Kelly, New York, NY, BestClinical Research Paper, “PrognosticImpact of RT-PCR Based Detection ofPeritoneal Micrometastases inPancreatic Cancer Patients UndergoingCurative Resection.”

• Dr. K. Singh, Atlanta, GA, Best Poster,“Melanoma Without an EpidermalComponent: Metastatic or UniquePrimary Lesions?”

• Dr. C. Ihemelandu, Washington, DC,

Best Disparities-Related Paper,“Prognostic Factors for ImprovedSurvival in Black Patients withPancreatic Cancer.”

Poster Contest winners for 2009 are:• Dr. P. Gaut, Houston, TX, Best BasicScience Poster, “Establishment andCharacterization of Human MidgutCarcinoid Cell Lines: EstablishingTargets for Therapy.”

• Dr. L. Wiechmann, New York, NY,Best Clinical Poster, “Presenting Featuresof Breast Cancer Differ by MolecularSubtype.” �

Testing for Hereditary Cancer Syndromes

As a surgical oncologist, you may see patients at risk for hereditary cancer.

• Up to 22% of patients with a breast or colon cancer diagnosis may

be appropriate for hereditary cancer testing.1,2

• Hereditary cancer syndromes confer signifi cantly elevated lifetime cancer risks,

including increased risks of developing a second cancer.

• Surgical intervention may be signifi cantly different for an individual with a hereditary cancer syndrome.

Please respond today for more information about common hereditary cancer syndromes.

� YES! Send me a complimentary copy of the:

� HBOC DVD � HBOC VHS

� Lynch Syndrome DVD � Lynch Syndrome VHS

� YES! I want someone to contact me about hereditary

cancer syndromes.

� YES! I would like a complimentary Specimen Collection

and Transportation Kit. � HBOC Kit � Lynch Syndrome Kit

Name:

Address:

Phone: Email:

Comments:

Contact Myriad Genetic Laboratories, Inc. by visiting www.myriadtests.comor call 1-800-469-7423. Ask for an Account Executive in your area. SSOinsert2008

Myriad offers two videos to

provide education to you and

your patients about testing for

hereditary breast and ovarian

cancer syndrome (HBOC) and

Lynch Syndrome (HNPCC).

You will meet real patients

who have been tested for a

hereditary cancer syndrome,

hear their perspectives on

testing, and learn how results

were used to make important

healthcare decisions. Send for your free copy today!

A test for hereditary breast and

ovarian cancer syndrome

A test for Lynch Syndrome

(Hereditary nonpolyposis

colorectal cancer)

A test for adenomatous

polyposis syndromes

A test for hereditary melanoma

Identifi cation and testing of patients at-risk for hereditary cancer can help you individualize surgical management and reduce your patient’s risk of a future cancer.It begins with you.

Plan to attend the Wednesday, March 4, SSO dinner symposium on Demystifying Genetic Testing,

prior to the opening of the 62nd Annual Cancer Symposium,

March 5-8, in Phoenix, AZ. Myriad Genetic Laboratories, Inc. is

proud to provide an educational grant in support of this CME offering.

“Testing for hereditary cancer is an essential tool in my practice. It allows me to individualize patient care in my high risk patients and optimize surgical

interventions in the cancer patient. I cannot imagine practicing without this information.” Lisa Curcio, MD

Surgical Oncologist

20571_CASH_SSO_News.indd 120571_CASH_SSO_News.indd 1 12/9/08 2:40:43 PM12/9/08 2:40:43 PM

Testing for hereditary cancer syndromes is performed on a blood sample. Learn more about offering this testing to your patients today.

1. Dominguez FJ, et al. Cancer. 2005;104(9):1849-53. 2. Shannon KM, et al. Cancer. 2002;94(2):305-13. 3. Guillem JG, et al. Ann Surg Oncol. 2006;13(10):1296-321.

Myriad, the Myriad logo, BRACAnalysis, COLARIS, COLARIS AP, and MELARIS are either trademarks or registered trademarks of Myriad Genetics, Inc. in the United

States and other jurisdictions. ©2008

Lynch Syndrome• Endometrial cancer before age 50

• Colorectal cancer before age 50

• Multiple Lynch related primaries-including colorectal, endometrial, ovarian and gastric

Adenomatous Polyposis Syndromes• 10 or more cumulative colorectal adenomas

• Colorectal cancer <50

Hereditary Melanoma• 2 or more melanomas

• Melanoma and pancreatic cancer

Myriad Genetic Laboratories, Inc.

320 Wakara Way

Salt Lake City, Utah 84108-9930

www.myriadtests.com

Which of My Patients are At-Risk for Hereditary Cancer?Patients with any of the following personal or family history features may be candidates for hereditary cancer testing:

Hereditary Breast and Ovarian Cancer Syndrome• Breast cancer before age 50

• Ovarian cancer at any age

• Both breast and ovarian cancer

• Bilateral breast cancer

• 2 or more breast cancers, one under 50

• Women of Ashkenazi Jewish descent with

breast or ovarian cancer at any age

• A previously identifi ed BRCA mutation

Medical Management for Individuals with a Common Hereditary Cancer SyndromeThe Society of Surgical Oncology (SSO) and the American Society of Clinical Oncology (ASCO) jointly published

a review of the role of risk-reducing surgery in common hereditary cancer syndromes which details surgical

options for mutation carriers.3 Testing for hereditary cancer syndromes identifi es mutation carriers who may be

appropriate for these surgical interventions.

K. TRAHAN

20571_CASH_SSO_News.indd 220571_CASH_SSO_News.indd 2 12/9/08 2:40:52 PM12/9/08 2:40:52 PM